Regression of aflatoxin B1-induced hepatocellular carcinomas by reduced glutathione.
Reduced glutathione administered to rats bearing aflatoxin B1-induced liver tumors caused regression of tumor growth and resulted in survival of the animals. since glutathione is a harmless natural product, it merits further investigation as a potential antitumor drug for humans.
D016604:Aflatoxin B1; D000348:Aflatoxins; D000818:Animals; D005260:Female; D005978:Glutathione / Q000627:therapeutic use*; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D051381:Rats
D000348:Aflatoxins; D016604:Aflatoxin B1; D005978:Glutathione